|
LMBRD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85760296034232E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.40759667547286E-11 |
| Normal-vs-Stage2 |
2.41649999999094E-06 |
| Normal-vs-Stage3 |
2.35520000002598E-06 |
| Normal-vs-Stage4 |
5.342800E-03 |
| Stage1-vs-Stage2 |
5.460600E-01 |
| Stage1-vs-Stage3 |
5.963400E-01 |
| Stage1-vs-Stage4 |
8.955600E-01 |
| Stage2-vs-Stage3 |
4.044600E-01 |
| Stage2-vs-Stage4 |
6.226600E-01 |
| Stage3-vs-Stage4 |
8.488800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.46935846507313E-12 |
| Normal-vs-AfricanAmerican |
1.43929999996129E-06 |
| Normal-vs-Asian |
3.876400E-02 |
| Caucasian-vs-AfricanAmerican |
5.182100E-02 |
| Caucasian-vs-Asian |
4.551800E-01 |
| AfricanAmerican-vs-Asian |
1.414250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21750387549469E-11 |
| Normal-vs-Female |
7.48859996235751E-09 |
| Male-vs-Female |
7.867400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.29660002126764E-09 |
| Normal-vs-Extreme_Weight |
1.20410015291839E-10 |
| Normal-vs-Obese |
2.01350000006428E-07 |
| Normal-vs-Extreme_Obese |
1.382480E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.415000E-01 |
| Normal_Weight-vs-Obese |
2.269200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.512600E-01 |
| Extreme_Weight-vs-Obese |
2.763400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.954800E-01 |
| Obese-vs-Extreme_Obese |
8.601000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29959998318441E-09 |
| Normal-vs-Age(41-60Yrs) |
2.37520000334612E-08 |
| Normal-vs-Age(61-80Yrs) |
2.19746443264057E-12 |
| Normal-vs-Age(81-100Yrs) |
1.65935999999478E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.440200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.131200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.115200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.524200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.015200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.640600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.70069999697142E-09 |
| Normal-VS-Type2 PRCC |
4.49860038109762E-10 |
| Normal-VS-KIRP CIMP |
5.87789816819395E-11 |
| Normal-VS-Unclassified PRCC |
1.66610000240652E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.218220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.19849999999466E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.090000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.381600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.892600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.109740E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64840380129294E-11 |
| Normal-vs-N1 |
2.16049999999246E-05 |
| Normal-vs-N2 |
8.76929999726883E-08 |
| N0-vs-N1 |
7.102600E-01 |
| N0-vs-N2 |
6.583600E-02 |
| N1-vs-N2 |
1.226350E-01 |
|
|
